SECISBP2L and atherosclerosis: In the blood of patients with severe coronary heart disease, the frequency of Slan+ non-classical monocyte subtypes is significantly increased and shows enhanced exocytosis capacity, indicating its role in protecting atherosclerosis, but also suggesting that Slan protein expression may be an important biomarker for the progression of coronary heart disease (46).